DOCS Doximity (DOCS) Insider Trading, Ownership & Congress Trades
Software & IT · Services-computer programming services · CIK 0001516513
Form 144 · 8
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
173
13F, latest reported quarter
Conversions, 180 days
11
Codes C/M, not in net · no price filed
What the filings say about DOCS
Insiders, 180 days
-$1.0M net sold
4 sellers · 50% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 1 sold
Latest: sale, 2025-11-06
Planned sales (Form 144), 90 days
$666.5K
8 notices
Doximity insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Doximity, Inc. insiders sold a net $1.0M of stock across 141 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Sep 15, 2026.
- The trade is 2.6% of the 101,432 shares held after it.
- 2 other insiders sold within 30 days.
- 173 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Sitaram Siddharth sold about $80.2K of DOCS under a 10b5-1 plan on Oct 14, 2026; 2 other insiders sold within 30 days and 173 funds added in the latest 13F quarter.Context
- 44 earlier Form 4 trades (code P or S) here by this insider (44 sales), the last on Sep 1, 2026.
- The trade is 7.2% of the 27,923 shares held after it.
- 2 other insiders sold within 30 days.
- 173 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Wampler Kira Scherer sold about $57.8K of DOCS under a 10b5-1 plan on Oct 1, 2026; 2 other insiders sold within 30 days and 173 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Feb 12, 2025.
- The trade is 5.2% of the 24,744 shares held after it.
- 2 other insiders sold within 30 days.
- 173 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Yang Watkin Phoebe L. sold about $34.5K of DOCS under a 10b5-1 plan on Sep 30, 2026; 2 other insiders sold within 30 days and 173 funds added in the latest 13F quarter.Context
- 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Aug 13, 2026.
- The trade is 2.2% of the 96,045 shares held after it.
- 2 other insiders sold within 30 days.
- 173 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Sitaram Siddharth sold about $54.0K of DOCS under a 10b5-1 plan on Sep 15, 2026; 2 other insiders sold within 30 days and 173 funds added in the latest 13F quarter.Context
- 43 earlier Form 4 trades (code P or S) here by this insider (43 sales), the last on Aug 25, 2026.
- The trade is 7.2% of the 27,923 shares held after it.
- 3 other insiders sold within 30 days.
- 173 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Wampler Kira Scherer sold about $52.7K of DOCS under a 10b5-1 plan on Sep 1, 2026; 3 other insiders sold within 30 days and 173 funds added in the latest 13F quarter.141 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$1.0M over 180 days
-$666.5K over 90 days
more than 57% of Software & IT
Congress
no House purchase disclosed in the last 12 months
Funds
173 funds bought in last quarter
more than 68% of Software & IT
Revenue
+13.1% year over year
more than 57% of Software & IT
Margin
30.4% net margin
more than 92% of Software & IT
Buybacks
$91.6M repurchased, FY to 2026-06-30
more than 52% of Software & IT
Short interest
9.1% of the float short (float per yahoo 2026-10-26) · 3.5 days to cover · settled 2026-09-30
What changed in the last 30 days
Oct 16Chief Accounting Officer Sitaram Siddharth sold $80.2K under a 10b5-1 plan (Oct 14)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 14Officer SIDDHARTH SITARAM filed to sell $80.2K by Oct 14 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 5Director Wampler Kira Scherer sold $57.8K under a 10b5-1 plan (Oct 1)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 2Director Yang Watkin Phoebe L. sold $34.5K under a 10b5-1 plan (Sep 30)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 1Director KIRA WAMPLER filed to sell $57.8K by Oct 1 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Watch DOCS
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-49.7%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns DOCS: institutional holders (13F)
13F holdings, latest reported quarter
14,307,116 sh
$296.7M
6,387,099 sh
$132.5M
5,977,433 sh
$124.0M
5,922,188 sh
$122.8M
4,647,309 sh
$96.4M
Congress trades in DOCS
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-11-06 · disclosed 29 days later
$15,001 - $50,000
Bought 2025-08-25 · disclosed 29 days later
$15,001 - $50,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
DOCS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
SIDDHARTH SITARAM
Filed 2026-10-14
$80.2K
KIRA WAMPLER
Filed 2026-10-01
$57.8K
PHOEBE L YANG WATKIN
Filed 2026-09-30
$34.5K
SIDDHARTH SITARAM
Filed 2026-09-15
$54.0K
KIRA WAMPLER
Filed 2026-09-01
$52.7K
DOCS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Jacob Internet Fund
$1.5M position · as of 2026-05-31
3.4%
Global X HealthTech ETF
$640.5K position · as of 2026-05-31
2.6%
Harbor Long-Short Equity ETF
$308.4K position · as of 2026-07-31
2.0%
Invesco S&P MidCap 400 GARP ETF
$7.2M position · as of 2026-07-31
1.5%
First Trust Health Care AlphaDEX Fund
$14.4M position · as of 2026-07-31
1.4%
Harbor Active Small Cap ETF
$189.3K position · as of 2026-07-31
1.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Jeff Tangney
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$19.6M
-$34.1M
$2.2M
-56%
+110%
2024
$17.2M
$84.8M
$1.3M
+9%
+62%
2023
$298.9K
-$15.7M
$2.5M
-49%
+53%
2022
$243.7K
-$101.7M
$1.1M
-39%
+5%
2021
$243.4K
$217.5M
$3.2M
-2%
+10%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.0M sold by insiders over 180 days, 173 funds added last quarter, $666.5K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
DOCS financials
Revenue growth
+13.1%
XBRL, annual
Net margin
30.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$655.6M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM DOCS
| FY Mar 2026 | $644.9M |
| FY Mar 2025 | $570.4M |
| FY Mar 2024 | $475.4M |
| FY Mar 2023 | $419.1M |
| FY Mar 2022 | $343.5M |
| Jun 2026 | $156.6M |
| Mar 2026 | $145.4M |
| Dec 2025 | $185.1M |
| Sep 2025 | $168.5M |
| Jun 2025 | $145.9M |
| Mar 2025 | $138.3M |
| Dec 2024 | $168.6M |
| Sep 2024 | $136.8M |
At each fiscal year end
Single quarter
Net margin, TTM
+25.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM DOCS
| FY Mar 2026 | +30.4% |
| FY Mar 2025 | +39.1% |
| FY Mar 2024 | +31.0% |
| FY Mar 2023 | +26.9% |
| FY Mar 2022 | +45.1% |
| Jun 2026 | +15.5% |
| Mar 2026 | +13.2% |
| Dec 2025 | +33.3% |
| Sep 2025 | +36.8% |
| Jun 2025 | +36.5% |
| Mar 2025 | +45.2% |
| Dec 2024 | +44.6% |
| Sep 2024 | +32.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM DOCS
| FY Mar 2026 | $326.5M |
| FY Mar 2025 | $273.3M |
| FY Mar 2024 | $183.9M |
| FY Mar 2023 | $177.9M |
| FY Mar 2022 | $124.7M |
| Jun 2026 | $41.9M |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | $62.1M |
| Mar 2025 | $98.5M |
| Dec 2024 | $65.2M |
| Sep 2024 | $68.3M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity DOCS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt DOCS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+17.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity DOCS
| FY Mar 2026 | +19.3% |
| FY Mar 2025 | +22.5% |
| FY Mar 2024 | +15.8% |
| FY Mar 2023 | +12.2% |
| FY Mar 2022 | +32.8% |
| Jun 2026 | +17.2% |
| Mar 2026 | +19.3% |
| Dec 2025 | +23.8% |
| Sep 2025 | +24.6% |
| Jun 2025 | +24.3% |
| Mar 2025 | +22.5% |
| Dec 2024 | +21.2% |
| Sep 2024 | +19.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+14.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets DOCS
| FY Mar 2026 | +16.4% |
| FY Mar 2025 | +19.0% |
| FY Mar 2024 | +13.3% |
| FY Mar 2023 | +10.6% |
| FY Mar 2022 | +24.9% |
| Jun 2026 | +14.6% |
| Mar 2026 | +16.4% |
| Dec 2025 | +20.6% |
| Sep 2025 | +21.3% |
| Jun 2025 | +20.6% |
| Mar 2025 | +19.0% |
| Dec 2024 | +18.5% |
| Sep 2024 | +16.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
Return on invested capital DOCS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+19.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed DOCS
| FY Mar 2026 | +20.7% |
| FY Mar 2025 | +22.3% |
| FY Mar 2024 | +17.0% |
| FY Mar 2023 | +13.3% |
| FY Mar 2022 | +22.1% |
| Jun 2026 | +19.6% |
| Mar 2026 | +20.7% |
| Dec 2025 | +23.1% |
| Sep 2025 | +23.5% |
| Jun 2025 | +23.8% |
| Mar 2025 | +22.3% |
| Dec 2024 | +22.6% |
| Sep 2024 | +21.1% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
39.28x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing DOCS
| FY Mar 2026 | 23.54x |
| FY Mar 2025 | 52.28x |
| FY Mar 2024 | 37.37x |
| FY Mar 2023 | 61.09x |
| FY Mar 2022 | 75.49x |
| Jun 2026 | 24.40x |
| Mar 2026 | 23.54x |
| Dec 2025 | 36.90x |
| Sep 2025 | 58.06x |
| Jun 2025 | 52.43x |
| Mar 2025 | 52.28x |
| Dec 2024 | 53.39x |
| Sep 2024 | 50.08x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value DOCS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield DOCS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -27%, PEG needs growth
PEG, trailing DOCS
| FY Mar 2026 | n/a |
| FY Mar 2025 | 0.97x |
| FY Mar 2024 | 1.04x |
| FY Mar 2023 | n/a |
| FY Mar 2022 | 0.27x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | 1.84x |
| Sep 2025 | 1.30x |
| Jun 2025 | 1.13x |
| Mar 2025 | 0.97x |
| Dec 2024 | 1.08x |
| Sep 2024 | 1.06x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-03 | 2025-03 | 2024-03 | 2023-03 | |
|---|---|---|---|---|
| Revenue | $644.9M | $570.4M | $475.4M | $419.1M |
| Gross profit | $574.5M | $514.5M | $424.8M | $365.6M |
| Operating income | $214.9M | $227.8M | $163.9M | $125.1M |
| Net income | $196.1M | $223.2M | $147.6M | $112.8M |
| EPS (diluted) | 0.98 | 1.11 | 0.72 | 0.53 |
| Operating cash flow | $326.5M | $273.3M | $184.1M | $179.6M |
| Cash | $219.2M | $209.6M | $96.8M | $158.0M |
| Buybacks | $431.7M | $120.3M | $280.7M | $85.3M |
SEC XBRL, fiscal years, as known on 2026-10-27
DOCS Stock Sonar score 5/7 axes
Find similar shapesCompareDOCS ranks highest on profitability (84th percentile) and growth (57th), and lowest on insider conviction (28th), among Software & IT peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
DOCS filings, in plain words
Are Doximity insiders buying or selling DOCS?
In the 180 days to 2026-10-27, Doximity insiders were net sellers, a net $1.0M across purchases and sales reported on Form 4, by 4 sellers.
Have members of Congress traded DOCS?
Yes. In the year to 2026-10-27, 0 House members disclosed buying DOCS and 1 House member disclosed selling it; the latest on record is a sale by Jonathan Jackson dated 2025-11-06.
Are there planned insider sales of DOCS?
Yes. 8 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $666.5K of stock; the latest, by SIDDHARTH SITARAM, was filed 2026-10-14.
Read the full summary
In the 180 days to 2026-10-27, Doximity insiders were net sellers of DOCS, a net $1.0M across purchases and sales reported on Form 4 by 4 sellers. 50% of the 12 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-27, 0 members of Congress disclosed buying DOCS and 1 member disclosed selling it; the latest on record is a sale by Jonathan Jackson dated 2025-11-06. Insiders filed 8 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $666.5K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
